Cyclacel Pharmaceuticals, Inc. (CYCC)

CTI BioPharma Statistics

Total Valuation

CYCC has a market cap or net worth of $15.40 million. The enterprise value is $11.94 million.

Market Cap	15.40M
Enterprise Value	11.94M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CYCC has 1.58 million shares outstanding.

Current Share Class	1.58M
Shares Outstanding	1.58M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2,143.32%
Owned by Insiders (%)	83.36%
Owned by Institutions (%)	0.10%
Float	148,966

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,098.59
Forward PS	201.05
PB Ratio	3.16
P/TBV Ratio	5.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	852.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.00.

Current Ratio	5.60
Quick Ratio	5.20
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,950.23% and return on invested capital (ROIC) is -1,789.64%.

Return on Equity (ROE)	-1,950.23%
Return on Assets (ROA)	-160.18%
Return on Invested Capital (ROIC)	-1,789.64%
Return on Capital Employed (ROCE)	-413.06%
Revenue Per Employee	$1,167
Profits Per Employee	-$695,583
Employee Count	12
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, CYCC has paid $572,000 in taxes.

Income Tax	572,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.53% in the last 52 weeks. The beta is 0.04, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-97.53%
50-Day Moving Average	10.74
200-Day Moving Average	71.57
Relative Strength Index (RSI)	46.29
Average Volume (20 Days)	5,336,861

Short Selling Information

The latest short interest is 123,114, so 7.77% of the outstanding shares have been sold short.

Short Interest	123,114
Short Previous Month	19,649
Short % of Shares Out	7.77%
Short % of Float	82.65%
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, CYCC had revenue of $14,000 and -$8.35 million in losses. Loss per share was -$9.66.

Revenue	14,000
Gross Profit	14,000
Operating Income	-12.69M
Pretax Income	-22.73M
Net Income	-8.35M
EBITDA	-12.68M
EBIT	-12.69M
Loss Per Share	-$9.66

Balance Sheet

The company has $3.45 million in cash and $9,000 in debt, giving a net cash position of $3.44 million or $2.17 per share.

Cash & Cash Equivalents	3.45M
Total Debt	9,000
Net Cash	3.44M
Net Cash Per Share	$2.17
Equity (Book Value)	3.06M
Book Value Per Share	3.54
Working Capital	3.05M

Cash Flow

Operating Cash Flow	-10.75M
Capital Expenditures	n/a
Free Cash Flow	-10.75M
FCF Per Share	-$6.79

Margins

Gross Margin	100.00%
Operating Margin	-90,607.14%
Pretax Margin	-55,535.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CYCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-54.27%
FCF Yield	-69.92%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jul 7, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

CYCC has an Altman Z-Score of -168.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-168.08
Piotroski F-Score	1